Delivery Order SPE2DB24D2205-SPE2DB26FDSPK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,650.56 to AmerisourceBergen Drug Corp for Visipaque 320 mg/mL intravenous solution in 150 mL bottles. This competitive award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, reflects a firm fixed-price contract type with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Visipaque 320 mg/ml in 100ml bottles, valued at $1,001.34 under a Firm Fixed Price contract type. The award was made on October 8, 2025, with an ultimate completion date of October 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-competitive, competitively awarded transaction under an existing contract vehicle and does not utilize...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Visipaque 320 mg/ml infusion bottles (150 ml units) with a ceiling value of $4,126.40. This firm fixed-price delivery order, which is expected to be completed by August 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 billion through December 2026. The award was...
- The Defense Logistics Agency awarded a $2,503.35 delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Visipaque 320 mg/ml in 100ml bottles, a contrast medium used in medical imaging procedures. This firm fixed-price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX valued at $999,999,999.00 through December 2026), carries no set-aside designation and is scheduled...
- The Defense Logistics Agency awarded a $3,004.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Visipaque 320 mg/mL, a contrast agent used in medical imaging procedures. This award, made on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a child order under a larger contract vehicle. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $2,063.20 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml infusion bottles (150 ml) on August 28, 2025, with completion targeted for August 29, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $5,006.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Visipaque 320 mg/ml in 100 ml bottles. This contract, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award for pharmaceutical procurement supporting federal medical supply needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,283.00 to AmerisourceBergen Drug Corp for the supply of Visipaque 270 mg/ml in 100ml bottles. The contract, awarded on May 22, 2025, with an ultimate completion date of May 23, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the performing location for this order. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a $1,650.56 delivery order to AmerisourceBergen Drug Corp for Visipaque 320 mg/ml infusion bottles (150 ml) on September 25, 2025, with completion scheduled for September 26, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under the vendor's larger...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,296.38 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml in 100ml bottles. This competitively awarded, firm fixed price contract was executed on July 24, 2025, with an ultimate completion date of July 25, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB26FDSPKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,337.80 to AmerisourceBergen Drug Corp for Visipaque 320 mg/ml in 100ml bottles, with an ultimate completion date of October 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's medical supply procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical commodities to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The delivery order structure allows the government to procure specific medications as needed while maintaining established pricing and supplier relationships through the umbrella contract agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 10/21/25 |